ALPHA HIV Incidence and Mortality data, uMkhanyakude, South Africa
zar-umkhanyakude-alpha-him-2002-2017-v1
Africa Health Research Institute
Network for Analysing Longitudinal Population HIV/ AIDS data on Africa
DataFirst
2024-08-23
Nesstar Publisher
v4
ALPHA HIV Incidence and Mortality data
uMkhanyakude 2000-2016
ALPHA HIMU 2000-2016
zaf-alpha-himu-2000-2016-v1
Africa Health Research Institute
Network for Analysing Longitudinal Population HIV/ AIDS data on Africa
Dr Kobus Herbst
Dickman Gareta
Nesstar Publisher
Wellcome Trust
Bill and Melinda Gates Foundation
Demographic Surveillance System Data
Version 1: Edited, anonymised data available with restrictions
South Africa
The data covers the uMkhanyakude study area in KwaZulu-Natal, South Africa
The data is at the level of village.
Individuals
Event/transaction data
The dataset includes individual-level HIV data from demographic surveillance, verbal autopsy interviews, serological and sexual behaviour surveys, and individually-linked data from HDSS and medical facilities.
Africa Health Research Institute
Face-to-face
ALPHA data are harmonised datasets from ALPHA member sites and this dataset is from the Africa Health Research Institute.
Karonga (MW011)
Africa Health Research Institute
Herbst, K. et al. ALPHA HIV Incidence and Mortality Data, uMkhanyakude 2000-2016 [dataset].Version 1. Africa Health Research Institute [producer and distributor], 2022. https://data.ahri.org/index.php/catalog/1029
Access under a Creative Commons CC-BY-NC (Attribution, Non-Commercial use only) License
incidence_uMkhanyakude.NSDstat
0
15
Nesstar 200801
mortality_uMkhanyakude.NSDstat
0
14
Nesstar 200801
Study name
0
0
1
Karonga
2
Kisesa
3
Manicaland
4
Masaka
5
Rakai
6
uMkhanyakude
7
Agincourt
8
Kisumu
9
Ifakara
10
Nairobi
Participant ID number
0
0
Sex
0
0
1
Men
2
Women
Calendar year, grouped in 4 years post 2005
0
0
0
1995-99
1
2000-04
2
2005-08
3
2009-12
4
2013-16
5
2017-20
6
2021-24
Five year age group
0
0
0
0-4
1
5-9
2
10-14
3
15-19
4
20-24
5
25-29
6
30-34
7
35-39
8
40-44
9
45-49
10
50-54
11
55-59
12
60-64
13
65-69
14
70-74
15
75-79
16
80-84
17
85-89
18
90+
Start of episode (age)
0
0
End of episode (age)
0
0
Age at last negative test
0
0
Age at first positive test
0
0
Seroconversion occurred at the end of this episode
0
0
0
No
1
Yes
Stata variable: age at start of episode
0
0
Stata variable: age at end of episode
0
0
Stata variable: in survival analysis
0
0
Stata variable: failure (seroconversion)
0
0
0
0
Study name
0
0
1
Karonga
2
Kisesa
3
Manicaland
4
Masaka
5
Rakai
6
uMkhanyakude
7
Agincourt
8
Kisumu
9
Ifakara
10
Nairobi
Participant ID number
0
0
Sex
0
0
1
Men
2
Women
Calendar year, grouped in 4 years post 2005
0
0
0
earliest-1999
1
2000-04
2
2005-08
3
2009-12
4
2013-16
5
2017-20
6
2021-24
Five year age group
0
0
0
0-4
1
5-9
2
10-14
3
15-19
4
20-24
5
25-29
6
30-34
7
35-39
8
40-44
9
45-49
10
50-54
11
55-59
12
60-64
13
65-69
14
70-74
15
75-79
16
80-84
17
85-89
18
90+
HIV status
0
0
1
Negative
2
Positive
3
Unknown
Start of episode (age)
0
0
End of episode (age)
0
0
Seroconversion occurred at the end of this episode
0
0
0
No
1
Yes
Stata variable: age at start of episode
0
0
Stata variable: age at end of episode
0
0
Stata variable: in survival analysis
0
0
Stata variable: failure (seroconversion)
0
0
0
0